A year ago, March 17, 2020, it was day 1 of the first confinement … In the streets, nobody or almost if it is not a few ambulances and intensive care units crowded with patients with severe form of Covid-19. Facing them are caregivers in need of equipment – masks, gloves or gowns … Since the masks are manufactured in number, especially in Angers at the manufacturer Kolmi-Hopen, but also in Brittany in the new La Coop des masques factory , and in Nantes start-ups are working on drugs like Xenothera, or potential vaccines like Valneva and Ose Immunotherapeutics.
The CovePIT, no reminder
Particularity of CovePiT, it could attack all variants of the virus, and this anti-COVID vaccine would be active longer than others, requiring a booster. To develop it, Ose Immunotherapeutics used data from people who already had the disease, and the lab targeted proteins from the virus to target its mutations. Therefore, it is only developed “now”. Nicolas Poirier, Scientific Director of OSE Immunotherapeutics with Cédric Mané:
Nicolas Poirier 1
“..”
Nicolas Poirier 1
“..”
The biotech, supported by the City of Nantes, the State and the EU through financial aid, has undertaken to grant France a purchase option on the vaccine, a vaccine which could be available in early 2022.
Nicolas Poirier 1
“..”
Special day on Hit West “One year after the confinement of March 17”: reports and testimonials to find on our site.
– .
